Differing influences of dopamine agonists and antagonists on fos expression in identified populations of globus pallidus neurons

Neuroscience

Volumn 81, Issue 1, 1997, Pages 79-92

  Ruskin, D N ^a   Marshall, J F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Eticlopride; FluoroGold; Parvalbumin; Quinpirole; SKF 38393; Tracer

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ETICLOPRIDE; FLUOROGOLD; PARVALBUMIN; QUINPIROLE; TRACER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IONTOPHORESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FLUORESCENT DYES; GLOBUS PALLIDUS; IMMUNOHISTOCHEMISTRY; IONTOPHORESIS; MALE; NEURONS; PARVALBUMINS; PROTO-ONCOGENE PROTEINS C-FOS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SALICYLAMIDES; STILBAMIDINES;

EID: 0030867837     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00113-9     Document Type: Article

References (63)

1. Bannon M. J., Lee J.-M., Giraud P., Young A., Affolter H.-U., Bonner T. I. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. J. biol. Chem. 261:1986;6640-6642.
2. Beckstead R. M. A pallidostriatal projection in the cat and monkey. Brain Res. Bull. 11:1983;629-632.
3. Bergstrom D. A., Bromley S. D., Walters J. R. Apomorphine increases the activity of rat globus pallidus neurons. Brain Res. 238:1982;266-271.
4. Bergstrom D. A., Walters J. R. Neuronal responses of the globus pallidus to systemic administration of d-amphetamine: investigation of the involvement of dopamine, norepinephrine, and serotonin. J. Neurosci. 1:1981;292-299.
5. Berretta S., Robertson H. A., Graybiel A. M. Dopamine and glutamate agonists stimulate neuron-specific expression of Fos-like protein in the striatum. J. Neurophysiol. 68:1992;767-777.
6. Bhatia K. P., Marsden C. D. The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain. 117:1994;859-876.
7. 2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6:1986;3177-3188.
8. Canteras N. S., Shammah-Lagnado S. J., Silva B. A., Ricardo J. A. Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res. 513:1990;43-59.
9. Carlson J. H., Bergstrom D. A., Demo S. D., Walters J. R. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation. Eur. J. Pharmac. 152:1988;289-300.
10. Carlson J. H., Bergstrom D. A., Demo S. D., Walters J. R. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus. Synapse. 5:1990;83-93.
11. Carlson J. H., Bergstrom D. A., Walters J. R. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists. Eur. J. Pharmac. 23:1986;237-251.
12. Cenci M. A., Cambell K., Wictorin K., Bjorklund A. Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra. Eur. J. Neurosci. 4:1992;376-380.
13. Cole D. G., Di Figlia M. Reserpine increases Fos activity in the rat basal ganglia via a quinpirole-sensitive mechanism. Neuroscience. 60:1994;115-123.
14. Cooper A. J., Moser B., Mitchell I. J. A subset of striatopallidal neurons are Fos-immunopositive following acute monoamine depletion in the rat. Neurosci. Lett. 187:1995;189-192.
15. Cote T. E., Eskay R. L., Frey E. A., Grewe C. W., Munemura M., Stoof J. C., Tsuruta K., Kebabian J. W. Biochemical and physiological studies of the beta-adrenoreceptor and the D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland. Neuroendocrinology. 35:1982;217-224.
16. 1 dopamine receptor. Nature. 347:1990;72-76.
17. DeLong M. Activity of pallidal neurons during movement. J. Neurophysiol. 34:1971;414-427.
18. Deutch A. Y., Duman R. S. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience. 70:1996;377-389.
19. Ferre S., O'Connor W. T., Fuxe K., Ungerstedt U. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13:1993;5042-5406.
20. Filion M. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey. Brain Res. 179:1979;425-441.
21. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
22. Heizmann C. W. Parvalbumin, an intracellular calcium-binding protein; distribution, properties and possible roles in mammalian cells. Experientia. 40:1984;910-921.
23. Horak F. B., Anderson M. E. Influence of globus pallidus on arm movements in monkeys. I. Effects of kainic acid-induced lesions. J. Neurophysiol. 52:1984;290-304.
24. Kawaguchi Y. Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J. Neurosci. 13:1993;4908-4923.
25. 1 region) contain the calcium-binding protein parvalbumin. Brain Res. 416:1987;369-374.
26. Kawaguchi Y., Wilson C. J., Emson P. C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10:1990;3421-3438.
27. Kelland M. D., Soltis R. P., Anderson L. A., Bergstrom D. A., Walters J. R. In vivo characterization of two cell types in the rat globus pallidus which have opposite responses to dopamine receptor stimulation: comparison of electrophysiological properties and responses to apomorphine, dizocilpine, and ketamine anesthesia. Synapse. 20:1995;338-350.
28. Kincaid A. E., Albin R. L., Newman S. W., Penney J. B., Young A. B. 6-Hydroxydopamine lesions of the nigrostriatal pathway alter the expression of glutamate decarboxylase messenger RNA in rat globus pallidus projection neurons. Neuroscience. 51:1992;705-718.
29. Kita H. Parvalbumin-immunopositive neurons in rat globus pallidus: a light and electron microscopic study. Brain Res. 657:1994;31-41.
30. Kita H., Kitai S. T. Intracellular study of rat globus pallidus neurons: membrane properties and responses to neostriatal, subthalamic and nigral stimulation. Brain Res. 564:1991;296-305.
31. Kita H., Kitai S. T. The morphology of globus pallidus projection neurons in the rat: an intracellular staining study. Brain Res. 636:1994;308-319.
32. Konig J. F. R. and Klippel R. A. (1974) The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Robert E. Krieger Publishing Co., Huntington, New York.
33. 2 dopamine receptors in brain with subtype-specific antibodies. Proc. natn. Acad. Sci. U.S.A. 90:1993;8861-8865.
34. 2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10:1990;2587-2600.
35. 2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres. Brain Res. 632:1993;308-313.
36. Morizumi T., Hattori T. Separate neuronal populations of the rat globus pallidus projecting to the subthalamic nucleus, auditory cortex and pedunculopontine tegmental area. Neuroscience. 46:1992;701-710.
37. Nambu A., Llinas R. Electrophysiology of globus pallidus neurons in vitro. J. Neurophysiol. 72:1994;1127-1139.
38. Napier T. C., Simson P. E., Givens B. S. Dopamine electrophysiology of ventral pallidal/substantia innominata neurons: comparison with the dorsal globus pallidus. J. Pharmac. exp. Ther. 258:1991;249-262.
39. Pan H. S., Engber T. M., Chase T. N., Walters J. R. The effects of striatal lesion on turning behavior and globus pallidus single unit response to dopamine agonist administration. Life Sci. 46:1990;73-80.
40. Parent A., Bouchard C., Smith Y. The striatopallidal and striatonigral projections: two distinct fiber systems in primate. Brain Res. 303:1984;385-390.
41. Paul M. L., Graybiel A. M., David J.-C., Robertson H. A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
42. Pinnock R. D. Sensitivity of compacta neurones in the rat substantia nigra slice to dopamine agonists. Eur. J. Pharmac. 96:1983;269-276.
43. Rajakumar N., Rushlow W., Naus C. C. G., Elisevich K., Flumerfelt B. A. Neurochemical compartmentalization of the globus pallidus in the rat: an immunocytochemical study of calcium-binding proteins. J. comp. Neurol. 346:1994;337-348.
44. 2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
45. 1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats. Brain Res. 703:1995;156-164.
46. Scheel-Kruger J. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta neurol. scand. Suppl. 73:1986;1-50.
47. Schmued L., Phermsangngam P., Lee H., Thio S., Chen E., Truong P., Colton E., Fallon J. Collateralization and GAD immunoreactivity of descending pallidal efferents. Brain Res. 487:1989;131-142.
48. Schmued L. C., Fallon J. H. Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties. Brain Res. 377:1986;147-154.
49. Sivam S. P. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909. Molec. Brain Res. 35:1996;197-210.
50. 3) as a target for neuroleptics. Nature. 347:1990;146-151.
51. Staines W. A., Atmadja S., Fibiger H. C. Demonstration of a pallidostriatal pathway by retrograde transport of HRP-labeled lectin. Brain Res. 206:1981;446-450.
52. Staines W. A., Fibiger H. C. Collateral projections of neurons in the rat globus pallidus to the striatum and substantia nigra. Expl Brain Res. 56:1984;217-220.
53. 1. Nature. 350:1991;614-619.
54. Tang F., Costa E., Schwartz J. P. Increase of proenkephalin mRNA and enkephalin content of rat striatum after daily injection of haloperidol for 2 to 3 weeks. Proc. natn. Acad. Sci. U.S.A. 80:1983;3841-3844.
55. Thompson M. A., Sheng M. and Greenberg M. E. (1991) Membrane depolarization regulation of c-fos proto-oncogene transcription. In Neurotransmitter Regulation of Gene Transcription (eds Costa E. and Joh T.), pp. 17-35. Thieme Medical Publishers, Inc., New York.
56. Van Der Kooy D., Hattori T. Single subthalamic nucleus neurons project to both the globus pallidus and substantia nigra in rat. J. comp. Neurol. 192:1980;751-768.
57. 4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
58. Vargo J. M., Marshall J. F. Reduced eticlopride-induced Fos expression in caudate-putamen and globus pallidus after unilateral frontal cortex injury: relation to neglect. Neuroscience. 76:1997;1083-1095.
59. 2 agonist effects. Science. 236:1987;719-722.
60. 2 dopamine receptor mRNA in rat brain. Proc. natn. Acad. Sci. U.S.A. 88:1991;1859-1863.
61. White F. J. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. Eur. J. Pharmac. 135:1987;101-105.
62. Yang C. R., Mogenson G. J. Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens. Brain Res. 489:1989;237-246.
63. 1 dopamine receptors. Nature. 347:1990;76-80.